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1. Introduction 
Plant derived polyphenols have attracted a great deal of interest 
in recent years, because of their possible benefits on human 
health.
[1]
 
Stilbenoids are an important class of phenolic phytoalexins 
found in a number of plant families, including Vitaceae. Their 
structure is characterized by the presence of the 1,2-
diphenylethylene (stilbene) skeleton. The most famous example 
of which is trans-Resveratrol (3,5,4’-trihydroxystilbene, 1a), a 
phytoalexin produced by plants, particularly in grapevines, pines 
and legumes, via a metabolic sequence induced in response to 
biotic or abiotic stress factors.
[2]
 It has been proposed to be one of 
the components of red wines with beneficial effects to human 
cardiovascular health (French paradox).
[3]
 In addition to 
resveratrol, its oligomers, in particular the so-called “viniferins”, 
have also been found in plants as a results of infection or stress. 
Both monomeric and oligomeric stilbenes (oligostilbenoids) are 
reported to be potentially important cancer chemoprotective 
agents, being able to inhibit cellular events associated with 
carcinogenesis.
[4,5]
 Thus, a number of hydroxylated stilbenes 
derived from natural sources and possessing a range of 
interesting biological activities have been described in the 
literature.
[6]
 As a consequence, it is not surprising that several 
papers have been published on the synthesis and the evaluation of 
the antitumor activity of 1a and of its analogues.
[7]
 Additionally, 
both monomeric and oligomeric stilbenes have been described as 
potentially important antimicrobial, anti-HIV and anti-
inflammatory agents,
[8]
 in accordance to the enhanced biological 
properties exhibited by many high molecular weight 
polyphenols.
[9]
  
Due to the structural diversity and attractiveness of 
oligostilbenoids, different  studies were undertaken to fulfill their 
synthesis. Of particular significance are the works on biomimetic 
dimerization approaches by Sako
[10]
, Luo
[11]
, and Weber
[12]
 and 
on rational synthetic approaches by Sarpong
[13]
,  Nicolaou 
[14]
 
and,  most notably, Snyder
[15] groups. 
Another interesting chemical framework is the benzo[b]furan 
nucleus, which is prevalent in a wide variety of biologically 
active natural and unnatural compounds.
[16] 
Many benzo[b]furans, 
including the 2,3-disubstituted derivatives, are of interest because 
they exhibit a wide range of biological activities,
[17]
 including, for 
example, anticancer effect.
[18]
A number of synthetic approaches 
to this class of compounds have been introduced in recent 
years.
[19] 
Thus we reasoned that the enzyme-catalyzed oxidative 
dimerization and/or oligomerization of phenolic derivatives 
might also be a useful approach. In this context, a few years ago 
we have described the synthesis of a resveratrol dimer and of 
some new dimeric hydroxystilbenes by an approach that 
combines the application of chemical C-C bond coupling 
reactions and oxidoreductases,
[20] 
that is the ligation of phenols 
and aromatic carboxylic acids to give hydroxystilbenes followed 
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by oxidative dimerisation reactions catalyzed by laccases, a 
group of copper-containing oxidases.
[21]
  
Laccases are oxidoreductases (the so-called “blue oxidases”), 
widely distributed in fungi and in some bacteria and higher 
plants,  having high stability, and multiple industrial 
applications.
[22]
 These enzymes are able to catalyse the oxidation 
of a wide range of substrates by a radical catalyzed reaction 
mechanism.
[23]
  
With the aim of finding new dimeric hydroxystilbene 
derivatives possessing antioxidative power, we report here the 
chemo-enzymatic synthesis and the evaluation of the radical 
scavenger performances of a series of resveratrol-related dimers 
containing the benzo[b]furan framework. 
 
2. Results and discussion 
A few years ago we reported an investigation on the laccase-
catalyzed oxidative dimerization of a series of hydroxystilbene 
derivatives.
[20]
 affording 4-O-α-ß-5 (dihydrofuran-like) dimers as 
main products.  
Looking for an improved reaction protocol, it was found that 
the best conditions for the synthesis of these compounds were 
based on the use of the commercially available laccase from 
Trametes versicolor in a mildly shaken biphasic system made of 
an organic phase containing the substrate and a water phase 
containing the enzyme. Accordingly, resveratrol (1a) and the 
other hydroxystilbenes (1b-e) were dissolved in AcOEt, while 
the laccase was dissolved in an equal volume of 20 mM acetate 
buffer, pH 4.5. The biphasic systems were shaken at room 
temperature and monitored by TLC. When the products were 
prevalent with respect to the initial substrates, the reactions were 
quenched by phase separation followed by AcOEt extraction of 
the water solution. The organic solvent was evaporated and the 
products were isolated by flash chromatography and identified as 
the (E)-dehydrodimers (2a-e) by mono- and bi-dimensional
1
H- 
and 
13
C-NMR spectra.
[20]
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As shown in Scheme 1, the acetylated (E)-dehydrodimers (3a-e) 
have been then refluxed for 9 h in dry toluene containing an 
excess of the organic oxidant DDQ, and the resulting crude 
mixtures were deacetylated and purified by flash chromatography 
to give the new dimeric derivatives 5a-e in 74-99 % isolated 
yields. These new dimers were characterized by mass 
spectrometry and NMR (mono- and bi-dimensional 
1
H- and 
13
C-
NMR) analysis and identified as 2,3-diarylbenzo[b]furan 
derivatives: a common feature of all this dimeric product is the 
absence of the characteristic signals due to the 
dihydrobenzofuran ring protons (H-2 and H-3), indicating the 
removal of these adjacent protons as a consequence of the 
oxidation of the derivatives 2a-e; furthermore, the signal of the 
C-2 and C-3 benzofuran carbons in the 
13
C-NMR spectra of 5a-e 
are in the typical range of the double-bond carbons. 
As an example, the characterization of the oxidized dimer 
obtained from resveratrol is reported. The mass analysis (HRESI-
MS) of the isolated product showed a molecular ion peak 
[M+Na]
+
 at m/z 475.11469±1.1 Da (calculated 475.11521) and a 
molecular ion peak [M-H]
-
 at 451.11862±0.2 Da (calculated 
451.11871), consistent with a fully conjugated dimeric 
compound. The proposed structure of the oxidized dimer 5a was 
unambiguously confirmed by NMR analysis.  
Initial inspection of the 
1
H-NMR spectrum of 5a in DMSO-d6 
(Figure 1) showed the absence of the characteristic signals due to 
the dihydrobenzofuran ring protons (resonating in the precursor 
2a at  4.47, d, J = 7.96 Hz and 5.45 ppm, d, J = 7.96 Hz),
[20a] 
indicating the removal of these adjacent protons as a consequence 
of the oxidation of 2a. Furthermore, the signals of three different 
types of aromatic OH’s were present at  9.85, 9.40 and 9.21 
ppm (integrating for 1H, 2H and 2H, respectively), confirming 
the penta-phenolic structure. Additionally, the 
1
H-NMR and 
1
H-
1
H correlation spectroscopy (COSY) spectra (Figure 2) exhibited 
the presence of two ortho-coupled aromatic signals assignable to 
a p-hydroxyphenyl group in an AA’BB’ type of arrangement 
(multiplet at 6.79 ppm and 7.47 ppm,), protons related to two 3,5-
dihydroxyphenyl moieties in an A2B type of arrangement (triplet 
at 6.28 ppm, 1H; doublet at 6.32 ppm, 2H; triplet at 6.16 ppm, 1 
H; doublet at 6.45 ppm, 2 H), a set of protons coupled in an ABX 
system on a 1,2,4-trisubstituted benzene ring at 7.54 and 7.60 
ppm (integrating for 1H and 2H respectively) and two trans 
olefinic protons (doublets at 6.98 and 7.16 ppm). A complete 
assignments of the signals could be made on the basis of 
1
H,
13
C-
inverse detected single-quantum (HSQC)
[24]
 and multiple-bond 
(HMBC)
[25] 
correlation experiments, and the data are reported in 
Table 1. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1. 
1
H-NMR spectrum of conpound 5a 
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Figure 2. 
1
H-
1
H correlation (COSY) spectrum of conpound 5a 
 
 
 
 
Table 1: 
1
H and 
13
C NMR data for compounds 2a and 5a 
 H (mult., J Hz)  C 
framework 2aa 5a  2a a 5a 
4-hydroxyphenyl      
H-2,6 7.24 (BB’ multiplet) 7.47 (BB’ multiplet) C-1 133.28 nd 
H-3,5 6.85 (AA’ multiplet) 6.79 (AA’ multiplet) C-2,6 129.23 128.77 
OH  9.85 (bs) C-3,5 116.85 116.02 
   C-4 159.10 158.58 
benzofuran      
H-2 5.45 (d, 7.96) - C-2 94.72 151.30 
H-3 4.47 (d, 7.96) - C-3 58.52 115.75 
H-4 7.26 (broad s) 7.54 (broad s) C-4 124.62 117.92 
H-6 7.43 (dd, 8.26, 1.63) 7.60 (broad s) C-5 132.43 133.0 
H-7 6.87 (d, 8.26) 7.60 (broad s) C-6 129.29 123.64 
   C-7 110.81 111.63 
   C-8 161.30 153.1 
   C-9 132.81 nd 
3,5-dihydroxyphenyl      
H-2,6 6.20 (d, 2.16) 6.32 (d, 2.18) C-3,5 160.44 159.46 
H-4 6.29 (t, 2.16) 6.28 (t, 2.18) C-4 103.08 102.60 
OH  9.40 (bs) C-2,6 108.11 107.80 
   C-5 145.91 nd 
(3,5-dihydroxyphenyl)vinyl      
 5 
vinyl protons      
H-1 7.06 (d, 16.33) 7.16 (d, 16.36) C-1 129.80 128.67 
H-2 6.90 (d, 16.33) 6.98 (d, 16.36) C-2 127.92 128.34 
3,5-dihydroxyphenyl      
H-2,6 7.21 (d, 2.10) 6.45 (d, 2.09) C-3,5 160.22 158.95 
H-4 6.82 (t, 2.10) 6.16 (t, 2.09) C-4 103.43 102.60 
OH  9.21 (bs) C-2,6 106.42 105.09 
   C-5 141.46 nd 
a
ref. 20a 
 
 
Antioxidant activity 
The antioxidant activities of the hydroxystilbenes 1a-e and of 
their dimeric derivatives 2a-e and 5a-e were evaluated by using 
the well-known DPPH reduction method, that is by plotting the 
remaining percentage of DPPH as a function of the molar ratios 
of the compound over DPPH.
[26] 
The results are reported in Table 
2 and expressed as IC50 as a results of a mean of three 
determinations. As a general trend, it was found that the 
monomeric hydroxystilbenes 1a-e and the benzofuran derivatives 
5a-e show comparable antiradical activities, which are one order 
of magnitude higher than those of the dehydrodimers 2a-e. 
As an example, the resveratrol dehydrodimer 2a reacted with 
DPPH and reached a steady state after about 3 h, whereas the 
dimer 5a reached the steady state after approximately 1.5 h. An 
EC50value of (9.5 ± 0.4) x 10
-4 
mmol/ml was determined for the 
dehydrodimer 2a, a higher value with respect to the one obtained 
with resveratrol [(6.1 ± 0.3) x 10
-5
mmol/ml]. On the contrary, the 
new dimer 5a showed an EC50 of (1.1 ± 0.4) x 10
-4 
mmol/ml, 
comparable to that of resveratrol. 
These experimental results might be explained by analyzing 
the structural features of the two derivatives 2a and 5a. Thus, the 
molecules of -viniferin 2a and of 5-{5-[2-(3,5-
dihydroxyphenyl)vinyl]-2-(4-hydroxyphenyl)-benzofuran-3-
yl}benzene-1,3-diol 5a were modeled using HyperChem
TM
 and 
then optimized using the Polak-Ribière conjugate gradient 
minimisation to a final potential energy gradient of 0.05 kcal 
mole
-1
 Å
-1 
(Figure 3). Both these compounds possess a planar 
moiety defined by their stilbenic framework. However, in 5a the 
presence of a double bond between the C2-C3 carbon of the 
benzofuran ring makes the whole molecule almost planar. 
Specifically, this additional double bond leads to an extended 
resonance delocalization for the 4’-phenoxyl radical, as the spin 
density can flow to the adjacent ring. On the contrary, the 
absence of this olefinic double bond in 2a causes a decrease in 
the possible radical resonance delocalization and, consequently, a 
significant decrease in the antioxidant activity of this molecule. 
Table 2: antioxidant activities of the 
hydroxystilbenes 1a-e and of their dimeric 
derivatives 2a-e and 5a-e 
 
derivatives 
IC50 
(mmol/ml) 
1a 6.1.10-5 
2a 9.5.10-4 
5a 1.1.10-4 
1b 1.6.10-4 
2b 1.8.10-3 
5b 1.6.10-4 
1c 3.1.10-5 
2c 8.4.10-4 
5c 2.4.10-4 
1d 2.0.10-5 
2d 3.5.10-4 
5d 2.4.10-5 
1e 2.1.10-5 
2e 3.8.10-4 
5e 1.4.10-4 
 
 
Furthermore, as the C2-C3 double bond in 5a is in the cis 
conformation, the two aromatic rings linked at C-2 and C-3 are 
sterically hindered. As observed in a previous paper,
[3c]  
the spin 
delocalization of the 4-phenoxyl radical via the double bond is 
partially hampered by the lack of full co-planarity of the 
system. This effect might explain the observed slightly lower 
antioxidant activity of the derivative 5a with respect to 
resveratrol. 
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Figure 3. 3D structure visualization of molecules 2a and 5a. 
 
3. Conclusion 
We have reported here a convenient chemo-enzymatic 
synthesis of a new hydroxystilbene dimers containing the 
benzo[b]furans moiety and possessing an antioxidant activity 
comparable to that of the parent monomeric hydroxystilbenes. 
The proposed methodology can be useful for the synthesis of 
various 2,3-diaryl benzo[b]furan derivatives, a class of 
compounds that exhibits a wide range of biological activities, 
starting from suitable hydroxystilbenic precursors. 
4. Experimental 
4.1 General  
Laccase from Trametes versicolor was from Fluka and its 
activity was evaluated by monitoring the oxidation of ABTS 
[2,2’-azinobis(3-ethylbenzothiazoline-6-sulfonic acid)] at 436 
nm. An enzymatic solution (10 mL) was added to a 1 mL cuvette 
containing 20 mM acetate buffer pH 3.5 (890 L) and ABTS 
(100 L of a 10 mM solution of ABTS in H2O). One enzyme unit 
is defined as the amount of laccase that oxidizes 1 mol of ABTS 
per minute under these conditions (ABTS 29.3 mM
-1
cm
-1
). 
trans-Resveratrol were obtained from Sigma. Compounds 1b-
e were synthesized by Perkins condensation starting from the 
suitable substituted hydroxy-benzaldehydes and phenylacetic 
acids in the presence of acetic anhydride and triethylamine, as 
described elsewhere.
[20] 
TLC were performed on precoated silica gel 60 F254 plates. 
Flashchromatography were performed using silica gel 60 (70–
230 mesh).  
Mass spectra were recorded with ion-trap coupled with a gas 
chromatograph operating under EI conditions (electron energy 70 
eV). High resolution electrospray mass spectra (HRESI-MS) 
were acquired with an FT-ICR (Fourier Transfer Ion Cyclotron 
Resonance) instrument equipped with a 4.7 Tesla cryo-magnet. 
Samples were dissolved in MeOH and injected into the 
instrument equipped with its own ESI source. Spectra were 
recorded in the HR mode. 
NMR spectra were obtained at 400 MHz using a FT-NMR 
instrument. All spectra were run on solutions in DMSO with 
tetramethylsilane as external reference. Chemical shifts are 
reported in parts per million to high frequency of the reference 
and coupling constants J are in Hertz. 
Energy minimized stereostructures of 2a and 5a were obtained 
by MM+ calculation using HyperChem version 7.0 molecular 
modeling program(Hypercube, Inc., Gainesville, FL).  
Antiradical activity was determined by DPPH method:
[26]
 
spectrophotometric data were acquired using a UV/VIS 
spectrometer. 
 
4.2 General procedure for the oxidation of hydroxystilbenes 
catalyzed by T. versicolor laccase 
Hydroxystilbenes (1a-e) (0.70 mmol) were dissolved in AcOEt 
(10 mL), while the laccase (40 U) was dissolved in 20 mM 
acetate buffer, pH 4.5 (10 mL). The biphasic systems were 
shaken at 40ºC and monitored by TLC. When the TLC spots 
indicated that the products were prevalent with respect to the 
initial substrates (6-72h), the reaction was quenched by phase 
separation followed by AcOEt extraction of the water solution. 
The organic solvent was evaporated and the crude residue was 
purified by flash chromatography to give the dehydrodimer (2a-
e). The compounds were identified by comparison with the 
previously reported UV, mass, and 
1
H-NMR spectral data.
[20, 27]  
2a. Yield = 31%. TLC (PetEt:EtOAc:MeOH, 3:7:1): Rf = 0.5. 
EI
+
-MS (m/z): 454 (M
+
). 
2b. Yield = 29%. TLC (PetEt:AcOEt, 4:6): Rf  0.6. EI
+
-MS 
(m/z): 450 (M
+
). 
2c. Yield = 19%. TLC (PetEt:AcOEt, 5:5): Rf  0.26. EI
+
-MS 
(m/z): 510 (M
+
). 
2d. Yield = 22%. TLC (PetEt:AcOEt, 7:3): Rf  0.15. EI
+
-MS 
(m/z): 510 (M
+
). 
2e. Yield = 17%. TLC (PetEt:AcOEt, 6:4): Rf  0.14. EI
+
-MS 
(m/z): 570 (M
+
). 
 
4.3 General procedure for the acetylation of dehydrodimers 
A solution of dehydrodimer (2a-e) (0.15mmol) in acetic 
anhydride (1 ml) and pyridine (1 ml) was stirred overnight at 
room temperature. The reaction was monitored by TLC (PetEt-
AcOEt, 6:4).The organic solvent was evaporated and the crude 
residue containing the dimer acetate (3a-e) was used as such for 
the following oxidative step. 
3a.Yield = 88%. TLC (PetEt:EtOAc, 6:4): Rf = 0.6. EI
+
-MS 
(m/z): 664 (M
+
). 
 7 
3b. Yield = 71%. TLC (PetEt:AcOEt, 8:2): Rf  0.3. EI
+
-MS 
(m/z): 492 (M
+
). 
3c. Yield = 81%. TLC (PetEt:AcOEt, 6:4): Rf  0.4. EI
+
-MS (m/z): 
552 (M
+
). 
3d. Yield = 50%. TLC (CHCl3:CH3OH, 10:0.01): Rf  0.4. EI
+
-MS 
(m/z): 552 (M
+
). 
3e. Yield = 91%. TLC (CHCl3:CH3OH, 10:0.05): Rf  0.75. EI
+
-
MS (m/z): 612 (M
+
). 
 
4.4 General methodology for the oxidation of acetylated 
dehydrodimers 
A crude sample (0.15 mmol) of acetylated dehydrodimer (3a-e) 
and DDQ (2,3-dichloro-5,6-dicyano-p-benzoquinone, 1.9 eq) in 
toluene (25 ml) was stirred under reflux. DDQ was added into the 
reaction mixture every 15 h (totally 9.5 eq). The course of the 
reaction was monitored by TLC (toluene-acetone, 20:1). After 90 
hr, the organic solvent was evaporated and the crude residue 
containing the acetylated benzofuran derivative (4a-e) was 
purified by flash chromatography (PetEt-AcOEt-MeOH, 6:4) to 
remove the excess of DDQ. 
4a. Yield = 100%. TLC (Toluene:Acetone, 20:1): Rf  0.6. EI
+
-MS 
(m/z): 662 (M
+
) 
4b.Yield = 79%. TLC (Toluene:Acetone, 20:1): Rf  0.39. EI
+
-MS 
(m/z): 490 (M
+
) 
4c. Yield = 30%. TLC (Toluene:Acetone, 20:1): Rf  0.3. EI
+
-MS 
(m/z): 550 (M
+
) 
4d. Yield = 24%. TLC (Toluene:Acetone, 20:1): Rf  0.4. EI
+
-MS 
(m/z): 550 (M
+
) 
4e. Yield = 54%. TLC (Toluene:Acetone, 20:1): Rf  0.16. EI
+
-MS 
(m/z): 610 (M
+
) 
 
4.5 General methodology for the deacetylation of the acetylated 
benzofuran derivativs 
A solution of the acetylated benzofuran derivative (4a-e) (0.06 
mmol) and potassium hydroxide (150 mg) in methanol (20 ml) 
was stirred at room temperature. After 1 hr, the solution was 
diluted with cold water (15 ml) and then neutralized with 1% 
hydrochloric acid. The solution was extracted with ethyl acetate 
(each 10 ml, 3 times). The extract was washed with brine and 
then dried over sodium sulfate. After evaporation of the solvent, 
the residue was subjected to flash chromatography to give the 
products (5a-e) . 
5a. Yield 99%. EI
+
-MS (m/z): 452 (M
+
). 
1
H-NMR (400 MHz, 
DMSO-d6): δ = 6.16 (1H, t, 2.09 Hz, H-4 C); 6.28 (1H, t, 2.18 
Hz, H-4 B); 6.32 (2H, d, 2.18 Hz, H-2,6 B); 6.45 (2H, d, 2.09 Hz, 
H-2,6 C); 6.79 (2H, AA’ multiplet, H-3,5 A); 6.98 (1H, d, 16.36 
Hz, H-2 vinyl); 7.16 (1H, d, 16.36 Hz, H-1 vinyl); 7.47 (2H, BB’ 
multiplet, H-2,6 A); 7.54 (1H, broad s, H-4); 7.60 (1H, broad s, 
H-6); 7.60 (1H broad s, H-7); 9.21 (2H, bs, OH C); 9.40 (2H, bs, 
OH B); 9.85 (1H, bs, OH A). 
13
C-NMR (400 MHz, DMSO-d6): δ 
= 102.6 (C-4 B); 102.6 (C-4 C); 105.1 (C-2,6); 107.8 (C-2,6 B); 
111.6 (C-7); 115.8 (C-3); 116.0 (C-3,5 A); 117.9 (C-4); 123.6 (C-
6); 128.3 (C-2 vinyl); 128.8 (C-2,6 A); 128.7 (C-1 vinyl); 133.0 
(C-5); 151.3 (C-2); 153.1 (C-8); 158.6 (C-4 A); 158.9 (C-3,5 C); 
159.5 (C-3,5 B). 
5b. Yield: 80%. EI
+
-MS (m/z): 448 (M
+
) 
1
H-NMR (400 MHz, 
DMSO-d6): δ = 3.76 (3H, s, OCH3 C); 3.84 (3H, s, OCH3 B); 6.19 
(1H, d, 16.41 Hz, H-2 vinyl); 6.79 (2H, AA’ multiplet, H-3,5 A); 
6.92 (2H, AA’ multiplet, H-3,5 C); 7.09 (2H, AA’ multiplet, H-
3,5 B); 7.11 (1H, d, 16.41, H-1 vinyl); 7.41 (2H, BB’ multiplet, 
H-2,6 B); 7.43 (2H, BB’ multiplet, H-2,6 A); 7.52 (2H, BB’ 
multiplet, H-2,6 C); 7.52 (1H, s, H-4); 7.58 (2H, s, H-6, H-7); 
9.86 (1H, bs, OH). 
13
C-NMR (400 MHz, DMSO-d6): δ = 55.5 (2 
x OCH3);111.6 (2C, C-3, C-7); 114.6 (2C, C-3,5 C); 115.1 (2C, 
C-3,5 B); 116.0 (2C, C-3,5 A); 117.4 (C-4); 121.3 (C-1 A); 123.1 
(C-6); 124.6 (C-1 B); 126.9 (C-2 vinyl); 127.3 (C-1 vinyl); 128.1 
(2C, C-2,6 C); 128.6 (2C, C-2,6 A); 130.4 (C-1 C); 130.9 (C-9); 
131.1 (2C, C-2,6 B); 133.4 (C-5); 151.3 (C-2); 153.0 (C-8); 
158.5 (C-4 A); 159.2 (C-4 C); 159.2 (C-4 B). 
5c. Yield: 79%.EI
+
-MS (m/z): 508 (M
+
) 
1
H-NMR (400 MHz, 
DMSO-d6): δ = 3.72 (3H, s, C3-OCH3 C); 3.77 (3H, s, C3-OCH3 
B); 3.81 (3H, s, C4-OCH3 B); 3.85 (3H, s, C4-OCH3 C); 6.80 
(2H, AA’ multiplet, H-3,5 A); 6.94 (1H, d, 6.79 Hz, H-5 C); 7.03 
(1H, s, H-2 B); 7.05 (1H, d, 8.42 Hz, H-5 B); 7.10 (1H, d, 6.79 
Hz, H-6 C); 7.12 (1H, d, 8.42 Hz, H-6 B); 7.12 (1H, d, 16.1 Hz, 
H-2 vinyl);7.26 (2H, BB’ multiplet, H-2,6 A); 7.26 (1H, bs, H-2 
C); 7.27 (1H, d, 16.1 Hz, H-1 vinyl); 7.56 (1H, bs, H-4);7.61 
(2H, bs, H-6, H-7); 9.87 (1H, bs, OH). 
13
C-NMR (400 MHz, 
DMSO-d6): δ = 56.0 ( 4 x OCH3); 109.8 (C-2 C), 111.6 (C-7), 
112.4 (C-5 C), 112.9 (C-6 B), 113.7 (C-2 B), 116.0 (C-3), 116.1 
(C-3,5 A), 117.8 (C-4), 120.2 (C-6 C), 121.3 (C-1 A), 122.3 (C-5 
B), 123.1 (C-6), 125.0 (C-1 B), 127.3 (C-1 vinyl), 127.6 (C-2 
vinyl), 128.6 (C-2,6 A), 130.8 (C-1 C), 133.4 (C-5), 134.4 (C-9), 
148.8 (C-4 C), 148.9 (C-3 B), 149.3 (C-4 B), 149.5 (C-3 C), 
151.5 (C-2), 153.0 (C-8), 158.6 (C-4 A). 
5d. Yield: 99%.EI
+
-MS (m/z): 508 (M
+
) 
1
H-NMR (400 MHz, 
DMSO-d6): δ = 3.61 (3H, s, OCH3 A); 3.78 (3H, s, OCH3 C); 
3.84 (3H, s, OCH3 B); 4.06 (3H, s, OCH3); 6.79 (1H, d, 8.74 Hz, 
H-5 A); 6.94 (2H, AA’ multiplet, H-3,5 C); 7.04-7.07 (2H, 
multiplet, H-2,6 A); 7.10 (1H, s, H-4); 7.11 (2H, AA’ multiplet, 
H-3,5 B); 7.17 (1H, s, H-1,2 vinyl); 7.25 (1H, s, H-6); 7.42 (2H, 
BB’ multiplet, H-2,6 B); 7.54 (2H, BB’ multiplet, H-2,6 C); 9.44 
(1H, bs, OH). 
13
C-NMR (400 MHz, DMSO-d6): δ = 55.6 (OCH3 
C); 55.7 (OCH3 B); 55.8 (OCH3 A); 56.5 (OCH3); 105.3 (C-6); 
110.9 (C-2 A); 114.8 (2C, C-3,5 C); 115.1 (C-3); 115.8 (2C, C-
3,5 B); 116.2 (C-5 A); 120.3 (C-4); 120.3 (C-6 A); 121.5 (C-1 
A); 127.3 (C-1 vinyl); 127.5 (C-2 vinyl); 128.0 (2C, C-2,6 C); 
130.4 (C-1 C); 131.3 (C-1 B); 131.3 (2C, C-2,6 B); 132.2 (C-9); 
134.4 (C-5); 142.2 (C-8); 145.4 (C-7); 147.9 (C-3 A, C-4 A); 
151.2 (C-2); 159.2 (C-4 B); 159.3 (C-4 C).  
5e. Yield: 82%.EI
+
-MS (m/z): 568 (M
+
) 
1
H-NMR (400 MHz, 
DMSO-d6): δ = 3.62 (3H, s, OCH3 A); 3.74 (3H, s, C3-OCH3 C); 
3.77 (3H, s, C3-OCH3 B); 3.82 (3H, s, C4-OCH3 B); 3.84 (3H, s, 
C4-OCH3 C); 4.07 (3H, s, OCH3); 6.81 (1H, d, 8.0 Hz, H-5 A); 
7.03 (1H, d, 6.79 Hz, H-5 C); 7.03 (1H, d, H-5 B); 7.04 (1H, d, 
H-2 B); 7.09 (1H, d, 8.0 Hz, H-6 A); 7.13 (1H, d, 6.79 Hz, H-6 
C); 7.13 (1H, d, H-6 B); 7.14 (1H, bs, H-4); 7.16 (1H, d, 16.0 Hz, 
H-2 vinyl); 7.24 (1H, d, 16.0 Hz, H-1 vinyl); 7.26 (1H, bs, H-2 
C); 7.26 (1H, bs, H-2 A); 7.26 (1H, bs, H-6); 9.45 (1H, bs, OH). 
13
C-NMR (400 MHz, DMSO-d6): δ = 55.9 (2 x OCH3 B); 56.0 (2 
x OCH3 C); 55.7 (OCH3 A); 56.4 (OCH3); 105.0 (C-6); 109.5 (C-
2 A); 109.5 (C-2 C); 110.8 (C-4); 112.3 (C-5 C); 112.9 (C-6 B); 
113.7 (C-2 B); 116.0 (C-3); 116.1 (C-5 A); 120.1 (C-6 C); 120.3 
(C-6 A); 121.5 (C-1 A); 122.5(C-5 B); 125.0 (C-1 B); 127.4 (C-1 
vinyl); 127.8 (C-2 vinyl); 130.8 (C-1 C); 134.2 (C-5); 134.4 (C-
9); 142.1 (C-8); 145.4 (C-7); 147.9 (C-3 A); 149.0 (C-4 C); 149.0 
(C-4 A); 149.0 (C-3 B); 149.4 (C-4 B); 149.6 (C-3 C); 151.2 (C-
2); 
4.6 Antiradical activity 
The antioxidant activities of the compounds 1a-e, 2a-e and 
5a-e were determined using DPPH as a free radical, following the 
method described by Berset,
[26]
 using different concentrations 
(0.03-1 mM) of the compound to be tested. A methanolic 
Tetrahedron 8 
solution of compound  1a-e, 2a-e or 5a-e(100 L) was added to 
3.9 mL of a 0.06 mM DPPH methanolic solution. The decrease in 
absorbance at 515 nm was evaluated until the reaction reached a 
plateau (about 3 h). The percentage of residual DPPH at the 
steady state was reported onto a graph as a function of the molar 
ratio of antioxidant to DPPH. Antiradical activity was defined as 
the amount of antioxidant necessary to decrease the initial DPPH 
concentration by 50% (efficient concentration). 
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